Cases & Deals

  • Home
  • Practices
  • Medicxi Ventures participates in €18.5 million financing round of Alderaan Biotechnology

Share

Medicxi Ventures participates in €18.5 million financing round of Alderaan Biotechnology

December 2019

Client(s) Medicxi Ventures (UK) LLP

Jones Day advised Medicxi Ventures in connection with the €18.5 million financing round of Alderaan Biotechnology, a company engaged in the research and development of antibodies targeting certain molecules for the treatment of cancer.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.